CEACAM5 and colorectal carcinoma: The already known blood-based protein biomarkers like carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA 19-9) alone lack the sensitivity and specificity needed for early diagnosis of CRC [12,13,14] which underlines the importance to identify and validate additional, more sensitive blood-based markers or marker signatures.